SODIUM-HF: Study of Dietary Intervention Under 100 MMOL in Heart Failure

NCT02012179 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 806

Last updated 2023-01-31

No results posted yet for this study

Summary

SODIUM-HF is a multicenter clinical trial in ambulatory patients with chronic HF to evaluate the efficacy of a low sodium containing diet on a composite clinical outcome composed of of all-cause mortality, cardiovascular hospitalizations and cardiovascular emergency department visits. The hypothesis of this study is that patients following a low-sodium containing diet will have fewer clinical events (fewer hospital readmissions or emergency department visits, longer survival) than those randomized to Usual Care.

Conditions

Interventions

OTHER

Low sodium diet

Low sodium diet (65 mmol or 1500 mg/day)

Sponsors & Collaborators

  • University of Alberta

    lead OTHER

Principal Investigators

  • Justin Ezekowitz, MBBCh · University of Alberta

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-24
Primary Completion
2022-09-30
Completion
2023-01-31

Countries

  • Australia
  • Canada
  • Chile
  • Mexico
  • New Zealand

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02012179 on ClinicalTrials.gov